期刊文献+

中药对肥胖相关性肾病患者胰岛素抵抗及血尿酸水平的影响 被引量:1

Effect of traditional Chinese medicine on insulin resistance and serum uric acid level in patients with obesity related nephropathy
下载PDF
导出
摘要 目的:探讨中药对肥胖相关性肾病患者胰岛素抵抗及血尿酸水平的影响。方法:选取115例ORG患者分成治疗组及对照组,2组均进行药物、饮食及运动疗法,治疗组加服中药治疗1个月,记录治疗前后各项指标进行统计学分析。结果:总有效率治疗组优于对照组。2组干预1个月后体质量、腰围、体质量指数、血糖、空腹胰岛素、胰岛素抵抗指数及血尿素水平均下降,与治疗前比较差异有统计学意义,治疗组优于对照组。2组血液流变学指标较治疗前均有改善,差异有统计学意义,治疗组优于对照组。结论:ORG患者采用中药治疗可降低胰岛素抵抗指数及血尿酸水平,降低血脂、血压、血糖及体质量。 Objective: To investigate the effect of traditional Chinese medicine on insulin resistance and serum uric acid levels in patients with obesity related nephropathy. Methods: 115 cases of ORG patients were divided into treatment group and control group,treatment group and control group are treated by drugs, diet and exercise therapy for 1 months. The experimental group was treated with oral administration of traditional Chinese medicine. Record the indexes before and after treatment. The data of two groups were statistically analyzed. Results: The total effective rate of treatment group was significantly higher than the control group. After 1 month of intervention, body weight, waist circumference, BMI, blood glucose, fasting insulin, insulin resistance and blood urea levels were significantly decreased in both two groups, there was statistical significance before and after treatment, and all the indexes of the treatment group compared with the control group, the differences were statistically significant, and there was statistical significance before and after treatment, and all the indexes of the treatment group compared with the control group, the differences were statistically significant. The treatment group in improving blood rheology was significantly better than the control group. Conclusion: In ORG patients treated by Chinese medicine intervention, insulin resistance index and blood uric acid levels were significantly decreased, weight,blood glucose ,blood lipid and blood pressure also decreased, the effect was better than the control group.
出处 《中国中医基础医学杂志》 CSCD 北大核心 2017年第5期662-665,共4页 JOURNAL OF BASIC CHINESE MEDICINE
基金 河北省科技厅计划支撑项目(12277789)-中西医结合治疗肥胖相关性肾病的临床研究(申请专利号201510160620.6)
关键词 肥胖相关性肾病 中药治疗 胰岛素抵抗 血尿酸 Obesity related nephropathy Traditional Chinese medicine therapy Insulin resistance Serum uric acid
  • 相关文献

参考文献13

二级参考文献145

共引文献73

同被引文献30

引证文献1

二级引证文献1

  • 1中国医师协会外科医师分会肥胖和代谢病外科专家工作组,中国医师协会外科医师分会肥胖代谢外科综合管理专家工作组,中国肥胖代谢外科研究协作组,杨华,朱晒红,王存川.中国肥胖代谢外科数据库:2023年度报告[J].中华肥胖与代谢病电子杂志,2024,10(2):73-83. 被引量:6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部